- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Adia Nutrition Inc.: Adia Med Partners with America's #1 Health Talk Show Host, Dr. Asa Andrew, to Bring Breakthrough Stem Cell Therapies to the Spotlight | 217 | Newsfile | Winter Park, Florida--(Newsfile Corp. - December 1, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), one of the nation's leaders in Stem Cell Technology is excited to announce a partnership with 3X Physician... ► Artikel lesen | |
| 24.11. | Adia Nutrition Inc.: ADIA Nutrition Submits Patent-Pending Autism Protocol for Independent IRB Review - Clinical Study Launch Nears | 191 | Newsfile | Winter Park, Florida--(Newsfile Corp. - November 24, 2025) - ADIA Nutrition, Inc. (OTCQB: ADIA) announced today that, following the independent Institutional Review Board's (IRB) acceptance of its... ► Artikel lesen | |
| 19.11. | ADIA Nutrition Inc. to Host Webinar on HSCT for MS and Autoimmune Conditions with HSCT Warriors | 215 | Newsfile | Winter Park, Florida--(Newsfile Corp. - November 19, 2025) - ADIA Nutrition, Inc. (OTCQB: ADIA) invites all shareholders, supporters, and potential investors to join a live webinar tomorrow, Thursday... ► Artikel lesen | |
| 17.11. | ADIA Nutrition Inc. Requests SIC Code Update to 2836 (Biological Products) with SEC and OTC Markets | 150 | Newsfile | Winter Park, Florida--(Newsfile Corp. - November 17, 2025) - ADIA Nutrition, Inc. (OTCQB: ADIA), a leader in regenerative medicine, today announced it has filed with the SEC to update its Standard... ► Artikel lesen | |
| 12.11. | ADIA Nutrition files patent application for regenerative medicine protocol | 2 | Investing.com | ||
| 12.11. | Adia Nutrition Inc.: Adia Med Files Provisional Patent for Breakthrough Regenerative Medical Protocol | 301 | Newsfile | Winter Park, Florida--(Newsfile Corp. - November 12, 2025) - ADIA Nutrition, Inc. (OTCQB: ADIA), a leader in advanced regenerative health solutions, today announced the filing of a provisional patent... ► Artikel lesen | |
| 10.11. | Adia Nutrition Inc.: Game-Changing Alliance: Adia Labs and Axia | 197 | Newsfile | Winter Park, Florida--(Newsfile Corp. - November 10, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine and premium wellness solutions, today announced a strategic partnership... ► Artikel lesen | |
| ADIA NUTRITION Aktie jetzt für 0€ handeln | |||||
| 05.11. | Adia Nutrition Inc. Announces Transformative 2025 Milestones and Strategic Progress Toward Nasdaq Uplisting | 279 | Newsfile | Winter Park, Florida--(Newsfile Corp. - November 5, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a leader in regenerative medicine and premium wellness solutions, today recaps its pivotal year-to-date... ► Artikel lesen | |
| 28.10. | Adia Nutrition Inc.: Adia Nutrition Thrilled to Announce to Shareholders Early Q3 Financials Release and Remarkable 200%+ Revenue Growth | 252 | Newsfile | Winter Park, Florida--(Newsfile Corp. - October 28, 2025) - Adia Nutrition (OTCQB: ADIA) is thrilled to announce the early release of its Q3 financial results, a powerful testament to the exceptional... ► Artikel lesen | |
| 21.10. | Adia Nutrition Inc. Appoints Dr. Evan Thomas, MD, PhD, to Drive Adia Med's Specialized Treatment Revolution | 120 | Newsfile | Winter Park, Florida--(Newsfile Corp. - October 21, 2025) - Adia Nutrition Inc. (OTCQB: ADIA) is excited to announce the appointment of Evan Thomas, MD, PhD, as an Independent Medical Director for... ► Artikel lesen | |
| 14.10. | Adia Nutrition Inc.: Adia Nutrition Paves Way for Nasdaq and New Investors Through SEC Form 10 Submission | 140 | Newsfile | Winter Park, Florida--(Newsfile Corp. - October 14, 2025) - Adia Nutrition Inc. (OTCQB: ADIA) is thrilled to announce a major milestone in its growth journey. The Company has engaged an independent... ► Artikel lesen | |
| 08.10. | Adia Nutrition Inc. Delivers Explosive Third Quarter Growth: Revenue Surges Over 100% from Prior Quarter, with Remarkable Profit Margin Exceeding 20% | 210 | Newsfile | Winter Park, Florida--(Newsfile Corp. - October 8, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a trailblazer in umbilical cord stem cells and exosome sales and therapies, today announced phenomenal... ► Artikel lesen | |
| 06.10. | Adia Nutrition sells Biolete coffee subsidiary to focus on healthcare | 2 | Investing.com | ||
| 06.10. | Adia Nutrition Inc. Divests Biolete Coffee Subsidiary to Cement Factory LLC, Retains 18% Ownership to Support Strategic Focus on Regenerative Medicine and Medical Sales | 226 | Newsfile | Winter Park, Florida--(Newsfile Corp. - October 6, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), an emerging leader in regenerative medicine and innovative healthcare solutions, today announced the sale... ► Artikel lesen | |
| 09.09. | Adia Nutrition Inc.: Adia Nutrition Expands Rapidly, Tripling Sales Force with Regional Teams to Fuel U.S. and Worldwide Growth | 302 | Newsfile | Winter Park, Florida--(Newsfile Corp. - September 9, 2025) - Adia Nutrition, Inc. (OTCQB: ADIA), an emerging leader in regenerative medicine, is excited to announce a rapid expansion of its sales operations... ► Artikel lesen | |
| 04.09. | Adia Nutrition Inc. Identifies Over 20 Million Potentially Improperly Issued Shares and Initiates Process to Return Shares to Treasury | 222 | Newsfile | Winter Park, Florida--(Newsfile Corp. - September 4, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a publicly traded company focused on advancing stem cell therapies for orthopedics, pain management,... ► Artikel lesen | |
| 02.09. | Adia Nutrition Inc.: Adia Med Finalizing In-Network Access with the Nation's Largest Health Insurers Including Medicare, Medicaid, Humana, Cigna, and Florida Blue | 497 | Newsfile | Winter Park, Florida--(Newsfile Corp. - September 2, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a rising name in regenerative medicine, is thrilled to announce a transformative step toward expanding... ► Artikel lesen | |
| 28.08. | Adia Nutrition Inc.: Adia Nutrition Joins PI Doctors Elite Community as Preferred Vendor Unlocking Access to a $50 Billion Personal Injury Care Market | 195 | Newsfile | Winter Park, Florida--(Newsfile Corp. - August 28, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a publicly traded company focused on regenerative medicine and personalized healthcare, announced that... ► Artikel lesen | |
| 26.08. | Adia Nutrition Inc.: Adia Med Surges Ahead of Growth Timeline With Venture Medical Partnership in $25B Wound Care Market | 237 | Newsfile | Winter Park, Florida--(Newsfile Corp. - August 26, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a bold leader in regenerative medicine and personalized healthcare, today announced a thrilling partnership... ► Artikel lesen | |
| 21.08. | Adia Nutrition Inc.: Adia Nutrition Launches Second National Television Campaign Showcasing U.S.-Based Regenerative Stem Cell Therapies | 241 | Newsfile | Winter Park, Florida--(Newsfile Corp. - August 21, 2025) - Adia Nutrition Inc. (OTCQB: ADIA), a publicly traded leader in regenerative medicine and personalized healthcare, today announced the launch... ► Artikel lesen |
1 2 3 Weiter >>
55 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 46,860 | +1,06 % | Fresenius Kabi Expands Simplist Portfolio of Prefilled Syringes | ||
| FRESENIUS MEDICAL CARE | 40,900 | +0,47 % | UBS stuft FMC FRESENIUS MEDICAL CARE AG auf 'Sell' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für FMC mit einem Kursziel von 38 Euro auf "Sell" belassen. Analyst Graham Doyle blieb in seiner Einschätzung vom Freitagabend... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 42,520 | -0,16 % | PRESSESPIEGEL/Unternehmen: SIEMENS HEALTHINEERS, INSTONE, BÖRSE STUTTGART, VOLKSWAGEN | DJ PRESSESPIEGEL/Unternehmen
Die wirtschaftsrelevanten Themen aus den Medien, zusammengestellt von Dow Jones Newswires.
SIEMENS HEALTHINEERS - Das größte Potenzial sieht Siemens-Healthineers-CEO... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 35,170 | -2,01 % | BMO Capital Maintains Bullish 12%+ BrightSpring EBITDA Growth Outlook on Drug Contract Wins, Generic Conversions | ||
| GERRESHEIMER | 25,620 | -4,12 % | INDEX-MONITOR: JPMorgan erwartet Aumovio im MDax - Dax wohl unverändert | FRANKFURT (dpa-AFX) - Im Dax dürfte zur Index-Überprüfung an diesem Mittwoch alles beim Alten bleiben. Eine Änderung erwartet die US-Bank JPMorgan dagegen im Index der mittelgroßen Unternehmen, die... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 42,940 | -0,88 % | RBC stuft CARL ZEISS MEDITEC AG auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat die Einstufung für Carl Zeiss Meditec mit einem Kursziel von 47 Euro auf "Sector Perform" belassen. Analyst Jack Reynolds-Clark geht skeptisch... ► Artikel lesen | |
| GENEDX | 162,95 | -0,28 % | GeneDx to Participate in Upcoming Investor Conferences | GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in upcoming investor conferences:
Stifel... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 18,985 | -0,55 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 29,320 | -3,55 % | PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance | SAN JOSE, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| PROGYNY | 24,900 | -1,43 % | Progyny, Inc. Announces Third Quarter 2025 Results | Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and... ► Artikel lesen | |
| PACS GROUP | 32,740 | -2,24 % | PACS Group, Inc. - 8-K, Current Report | ||
| OTTOBOCK | 71,50 | -1,31 % | Hausvorteil AG. Börsengang. Nach Ottobock, TKMS u.a. viel kleiner, aber… | Hausvorteil AG (ISIN: DE000A31C222) istheute am m:access "gestartet". Keiner dieser grossen, lauten Börsengänge,w ie bei Ottobock oder TKMS, sondern ein kleiner Player in einem Nischenmarkt. MicroCap... ► Artikel lesen | |
| UNITEDHEALTH | 279,25 | +0,25 % | Extreme Fear - als Kaufchance? United Health | Alphabet | Starbucks | Meta | Die neuen PCE-Inflationsdaten liegen unter den Erwartungen und erhöhen die Chance auf eine Zinssenkung im Dezember - das FedWatch-Tool springt auf über 85 %. Gleichzeitig bleibt der Fear & Greed Index... ► Artikel lesen | |
| BILLIONTOONE | 112,50 | -0,04 % | BillionToOne, Inc.: BillionToOne to Report Third Quarter 2025 Financial Results on December 9, 2025 | ||
| BETA BIONICS | 27,920 | -5,26 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen |
Das Unternehmen ADIA NUTRITION INC kann der Branche Gesundheitswesen zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ADIA NUTRITION INC finden Sie auf Wallstreet Online.